India to do second trial of Corona vaccine
India to do second trial of Corona vaccine
Share:

The second trial of covid-19 drug will start in India today. Phase-2 trials are very important, because with Phase-2 trials, the path of large-scale vaccine trials (Phase-3) is cleared. The drug from Oxford University prepared in India is named Covishield. Pune-based Serum Institute of India, Oxford University is working together on the Corona vaccine.

Here, the United States has been badly affected by the Corona Virus epidemic. President Donald Trump said that plasma therapy can be used for critically ill patients in emergencies. With this approval, many people's lives will be saved. According to Trump, this can reduce the death of corona in the country by up to 35 percent. So far, plasma therapy has been given to more than 70 thousand people in America.

For your information, let us tell you that America is the most influential in the world than Corona. According to the information on the corona, 59,15,630 people in the USA have been confirmed corona. Of these, 1,81,114 people have died. However the good thing is that 32,17,981 have been cured in total patients and there are 25,16,535 active cases. The condition of 61 thousand patients remains critical.

Also Read:

Heavy rain alert for three days issued in Haryana

PM Modi expresses grief over Raigad Building collapse

Telangana government gives permission for online classes, will start on September 1

30 percent companies have cut salaries of employees during pandemic

 

Join NewsTrack Whatsapp group
Related News